A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: family member (384), relative (245)

Chlorambucil_7day

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Chlorambucil (7 day) There are several versions of this protocol each using a different dose or c
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-7day.pdf

Chlorambucil_14day

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Chlorambucil (14 day) There are several versions of this protocol each using a different dose or
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-14day.pdf

Etoposide PO

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER ETOPOSIDE ORAL Regimen Ovary-Etoposide Oral Indication Second line or subsequent treatment of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/EtoposidePO.pdf

Cyclophosphamide PO

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CYCLOPHOSPHAMIDE ORAL Regimen Ovary – Cyclophosphamide Oral Indication Relapsed/refractory ova
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CyclophosphamidePO.pdf

Everolimus Ver 1

Description
Chemotherapy Protocol PANCREATIC NEUROENDOCRINE CARCINOMA EVEROLIMUS This protocol may require funding Regimen PNET - Everolimus Indicatio
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Everolimus-Ver-1.pdf

Temozolomide (200)

Description
Chemotherapy Protocol Central Nervous System TEMOZOLOMIDE (200) Regimen • CNS – Temozolomide (200) Indication • Recurrent or progressive mal
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Temozolomide-200.pdf

Information for Sponsors

Description
Dear Sponsor Representative, As part of our response to the COVID-19 pandemic, it has been necessary for University Hospital NHS Foundat
Url
/Media/Southampton-Clinical-Research/COVID-19/info-for-researchers-and-sponsors/Information-for-Sponsors.pdf

Can patients rely on their advance decisions?

Description
Advance decisions allow an adult to refuse lifesaving treatment in a future where they envisage they may lack capacity to deliver
Url
/HealthProfessionals/Clinical-law-updates/Can-patients-rely-on-their-advance-decisions.aspx

Carboplatin-Etoposide

Description
Regimen Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) CARBOPLATIN (AUC6)-ETOPOSIDE (Intravenous / Oral) • SCLC – Carboplatin (AUC6)
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Carboplatin-Etoposide-intravenous-and-oral.pdf

Carboplatin and Vinorelbine (intravenous and oral)

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN-VINORELBINE (Intravenous and Oral) Regimen • NSCLC – Carboplatin-Vinore
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CarboplatinandVinorelbineintravenousandoral.pdf
131 to 140 of 312
Previous … 12 13 14 15 16 … Next